Table 1.
Definition of low, moderate and high risk of a UGIE in each cohort
UGIE risk group | Definition in LDA cohort | Definition in NSAID cohort |
---|---|---|
High risk | At least one of the following high risk factors: | At least one of the following high risk factors: |
History of UGIE | History of UGIE | |
Age ≥ 80 | Age ≥ 70 | |
Age 70–79 and ≥ one other moderate risk factor | ≥ Two moderate risk factors | |
Age 60–69 and ≥ two moderate risk factors | ||
Moderate risk | No high risk and at least one of the following moderate risk factors: | No high risk and at least one of the following moderate risk factors: |
Age 70–79 | Age 60–69 years | |
Use of VKA | History of DM | |
Use of clopidogrel | History of HF | |
Use of a corticosteroid | History of severe RA | |
Use of SSRI | Use of VKA | |
Use of spironolactone | Use of LDA | |
Use of clopidogrel | ||
Use of a corticosteroid | ||
Use of an SSRI | ||
Use of spironolactone | ||
High-dose NSAID | ||
Low risk | No moderate or high risk | No moderate or high risk |
DM, diabetes mellitus; HF, heart failure; LDA, low-dose aspirin; NSAID, non-steroidal anti-inflammatory drug; RA, rheumatoid arthritis; SSRI, serotonin-reuptake inhibitor; UGIE, upper gastrointestinal event; VKA, vitamin K antagonist.